Prevalence Of Polycystic Ovary Syndrome Among Reproductive Age Women: A Rural Based Cross Sectional Study
Keywords:
Polycystic ovarian syndrome, prevalence, rural, reproductive age womenAbstract
Introduction: Polycystic ovary syndrome (PCOS) affects 5–13% of reproductive-aged women, leading to reproductive, metabolic, and psychological challenges. Complications like gestational diabetes and hypertension are common in affected women. This study aims to assess the prevalence and associated factors of PCOS among reproductive-aged women, enhancing awareness and improving management through targeted interventions.
Materials and Methods: This study employed a quantitative, descriptive cross-sectional design in Gautam Budha Nagar, Greater Noida, targeting women aged 15–49 years. A sample of 100 women was selected through convenience sampling. Inclusion criteria included reproductive-aged women, while pregnant or breastfeeding women and those with other androgen excess conditions were excluded. A self-structured questionnaire assessed PCOS symptoms and demographic factors. Data analysis involved descriptive and inferential statistics.
Results: Of the participants, 54% indicated a high likelihood of PCOS, 34% moderate, and 12% low. Irregular periods and excessive hair growth were reported by 53% and 59% of participants, respectively. The study reveals significant correlations among various symptoms of Polycystic Ovary Syndrome (PCOS). Irregular periods positively correlated with increased facial hair growth (r = .356, p < 0.01) and waist weight gain (r = .275, p < 0.01). Heavy menstrual bleeding was strongly associated with insulin resistance (r = .355, p < 0.01) and difficulty conceiving (r = .355, p < 0.01). Notably, symptoms of insulin resistance had a perfect correlation with challenges in conceiving (r = 1.000, p < 0.01) and were positively linked to ovarian cyst diagnoses (r = 1.000, p < 0.01), highlighting the intricate interconnections among these symptoms.
Discussion: Findings underscore the need for improved awareness and targeted interventions for PCOS in diverse populations, particularly in rural areas where healthcare access is limited. Further research should explore the influence of lifestyle and environmental factors on PCOS prevalence and symptomatology
Downloads
Metrics
References
World Health Organization: WHO & World Health Organization: WHO. (2023, June 28). Polycystic ovary syndrome. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome#:~:text=Polycystic%20ovary%20syndrome%20(PCOS)%20is,and%20cysts%20in%20the%20ovaries.
Jabeen, A., Yamini, V., Amberina, A. R., Eshwar, M. D., Vadakedath, S., Begum, G. S., & Kandi, V. (2022b). Polycystic Ovarian Syndrome: prevalence, predisposing factors, and awareness among adolescent and young girls of South India. Cureus. https://doi.org/10.7759/cureus.27943
McDonnell, R., & Hart, R. J. (2017). Pregnancy-related outcomes for women with polycystic ovary syndrome. Women S Health, 13(3), 89–97. https://doi.org/10.1177/1745505717731971
Mohammad, M. B., & Seghinsara, A. M. (2017b). Polycystic ovary Syndrome (PCOS), diagnostic criteria, and AMH. PubMed, 18(1), 17–21. https://doi.org/10.22034/apjcp.2017.18.1.17
Tay, C. T., Mousa, A., Vyas, A., Pattuwage, L., Tehrani, F. R., & Teede, H. (2024). 2023 International Evidence‐Based Polycystic Ovary Syndrome Guideline Update: Insights from a Systematic Review and Meta‐Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome. Journal of the American Heart Association, 13(16). https://doi.org/10.1161/jaha.123.033572
Tay, C. T., Garrad, R., Mousa, A., Bahri, M., Joham, A., & Teede, H. (2023). Polycystic ovary syndrome (PCOS): international collaboration to translate evidence and guide future research. Journal of Endocrinology, 257(3). https://doi.org/10.1530/joe-22-0232
Wang, Q., Wang, H., Li, P., Li, X., Wang, Z., Yan, L., & Shi, Y. (2022). Association of polycystic ovary syndrome phenotypes with adverse pregnancy outcomes after In-Vitro Fertilization/Intracytoplasmic sperm injection. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.889029
World Health Organization: WHO & World Health Organization: WHO. (2023b, June 28). Polycystic ovary syndrome. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovarysyndrome#:~:text=Polycystic%20ovary%20syndrome%20(PCOS)%20affects,affecting%20women%20of%20reproductive%20age.
World Health Organization: WHO & World Health Organization: WHO. (2023b, June 28). Polycystic ovary syndrome. https://www.who.int/news-room/fact-sheets/detail/polycystic-ovary-syndrome
Ovalle, F., & Azziz, R. (2002). Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fertility and Sterility, 77(6), 1095–1105. https://doi.org/10.1016/s0015-0282(02)03111-4
Polycystic ovary Syndrome (PCOS). (2024b, July 2). Johns Hopkins Medicine. https://www.hopkinsmedicine.org/health/conditions-and-diseases/polycystic-ovary-syndrome-pcos#:~:text=PCOS%20is%20a%20very%20common%20hormone%20problem%20for%20women%20of,%2C%20infertility%2C%20and%20weight%20gain.
Dason, E. S., Koshkina, O., Chan, C., & Sobel, M. (2024). Diagnosis and management of polycystic ovarian syndrome. Canadian Medical Association Journal, 196(3), E85–E94. https://doi.org/10.1503/cmaj.231251
Robinson, S., Rodin, D. A., Deacon, A., Wheeler, M. J., & Clayton, R. N. (1992). Which hormone tests for the diagnosis of polycystic ovary syndrome? BJOG an International Journal of Obstetrics & Gynaecology, 99(3), 232–238. https://doi.org/10.1111/j.1471-0528.1992.tb14505.x
Polycystic ovary syndrome (PCOS) - Symptoms and causes. (n.d.). Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/pcos/symptoms-causes/syc-20353439
Lim, S. S., Hutchison, S. K., Van Ryswyk, E., Norman, R. J., Teede, H. J., & Moran, L. J. (2019). Lifestyle changes in women with polycystic ovary syndrome. Cochrane Library, 2019(3). https://doi.org/10.1002/14651858.cd007506.pub4
Kusuma, P., Anusha, D. V. B., Jagannivas, S. S., Shridevi, K., & Krishna, N. V. (2021). A cross sectional study on, prevalence of polycystic ovarian syndrome and its health effects, in reproductive age women (15-45 years) in a rural area, Telangana, India. International Journal of Clinical Obstetrics and Gynaecology, 5(3), 371–376. https://doi.org/10.33545/gynae.2021.v5.i3f.949
Lujan, M. E., Chizen, D. R., & Pierson, R. A. (2008). Diagnostic criteria for Polycystic ovary Syndrome: pitfalls and controversies. Journal of Obstetrics and Gynaecology Canada, 30(8), 671–679. https://doi.org/10.1016/s1701-2163(16)32915-2
Balaji, S., Amadi, C., Prasad, S., Kasav, J. B., Upadhyay, V., Singh, A. K., Surapaneni, K. M., & Joshi, A. (2015). Urban Rural Comparisons of Polycystic Ovary Syndrome Burden among Adolescent Girls in a Hospital Setting in India. BioMed Research International, 2015, 1–10. https://doi.org/10.1155/2015/158951
Stegehuis, N., Kotsirilos, V., & Parker, J. (2024). The impact of microparticulate air pollution in polycystic ovary Syndrome: A Narrative review. Clinical and Experimental Obstetrics & Gynecology, 51(10). https://doi.org/10.31083/j.ceog5110233
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
